Featured Research

from universities, journals, and other organizations

Epilepsy: Exposure To Valproate During Pregnancy Can Impair A Child's Cognitive Development

Date:
April 21, 2009
Source:
Emory University
Summary:
Three-year-olds whose mothers took the antiepileptic drug valproate during pregnancy had average IQs six to nine points lower than children exposed to three other antiepileptic drugs, a landmark multi-center study has found.

Three-year-olds whose mothers took the antiepileptic drug valproate during pregnancy had average IQs six to nine points lower than children exposed to three other antiepileptic drugs, a landmark multi-center study has found.

The study's authors say that women of childbearing age should avoid valproate as a first choice drug for the treatment of epilepsy.

The Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) study is following more than 300 children born to women with epilepsy between 1999 and 2004. Investigators at 25 epilepsy centers in the United States and the United Kingdom are participating. At enrollment, the women were taking a single antiepileptic agent: carbamazepine, lamotrigine, phenytoin or valproate.

The NEAD study previously found that valproate exposure also increases the risk of anatomical birth defects, even though it was not designed to look for them.

"There are clear risks associated with valproate, and physicians have an obligation to inform women about them," says lead study author Kimford Meador, MD, professor of neurology at the Emory University School of Medicine. "Valproate still has an important role in treating epilepsy, because some patients' seizures can only be controlled with valproate. However, we are recommending that women with epilepsy try another drug first."

Around 15 percent of patients with primary generalized epilepsy respond only to valproate, but this selectivity does not apply to other forms of epilepsy, Meador says.

Meador stresses that women who are pregnant and take valproate should not stop without consulting a physician, to avoid seizures with potentially serious consequences.

Valproate's effects on child IQ appear to be dose-dependent, so it may be possible to reduce risk by taking it in lower doses more frequently or in a sustained release formulation, Meador says.

A child's IQ is usually strongly influenced by the mother's IQ. Out of the four antiepileptic drugs studied, only valproate disrupted this relationship.

Preliminary results describing the children's IQs at 2 years of age were reported at the end of 2006. The studies' findings were strengthened by researchers' ability to include more children and measure their progress after three years. The researchers plan to follow the children until age 6.

Valproate is also prescribed for bipolar disorder and migraine headaches. It is sold under the brand name Depakote. Last year the FDA approved a generic version.

The NEAD study was funded by the National Institute of Neurological Disorders and Stroke and the United Kingdom Epilepsy Research Foundation.


Story Source:

The above story is based on materials provided by Emory University. Note: Materials may be edited for content and length.


Journal References:

  1. Meador, K.J. et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. New England Journal of Medicine, April 16, 2009
  2. Meador et al. In utero antiepileptic drug exposure: Fetal death and malformations. Neurology, 2006; 67 (3): 407 DOI: 10.1212/01.wnl.0000227919.81208.b2

Cite This Page:

Emory University. "Epilepsy: Exposure To Valproate During Pregnancy Can Impair A Child's Cognitive Development." ScienceDaily. ScienceDaily, 21 April 2009. <www.sciencedaily.com/releases/2009/04/090415172227.htm>.
Emory University. (2009, April 21). Epilepsy: Exposure To Valproate During Pregnancy Can Impair A Child's Cognitive Development. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2009/04/090415172227.htm
Emory University. "Epilepsy: Exposure To Valproate During Pregnancy Can Impair A Child's Cognitive Development." ScienceDaily. www.sciencedaily.com/releases/2009/04/090415172227.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Fauci: Ebola Protocols to Focus on Training

Fauci: Ebola Protocols to Focus on Training

AP (Oct. 20, 2014) Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, says he expects revised CDC protocols on Ebola to focus on training, observation and ensuring health care workers are more protected. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins